FDA Announces Approval of New Drug Safety Reporting Requirements

Summary

The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to collect information on Investigational New Drug Safety Reporting Requirements for human drug and biological products, as well as safety reporting requirements for bioavailability and bioequivalence studies in humans, under the Paperwork Reduction Act of 1995.